LexAurum Advisors LLC Buys 403 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

LexAurum Advisors LLC increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,089 shares of the healthcare conglomerate’s stock after buying an additional 403 shares during the quarter. UnitedHealth Group accounts for about 1.0% of LexAurum Advisors LLC’s portfolio, making the stock its 25th largest position. LexAurum Advisors LLC’s holdings in UnitedHealth Group were worth $5,103,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in UNH. Dark Forest Capital Management LP lifted its position in UnitedHealth Group by 76.9% during the 2nd quarter. Dark Forest Capital Management LP now owns 734 shares of the healthcare conglomerate’s stock worth $374,000 after acquiring an additional 319 shares during the period. Matrix Private Capital Group LLC lifted its position in UnitedHealth Group by 3.6% during the 2nd quarter. Matrix Private Capital Group LLC now owns 542 shares of the healthcare conglomerate’s stock worth $276,000 after acquiring an additional 19 shares during the period. Scientech Research LLC acquired a new stake in UnitedHealth Group during the 2nd quarter worth about $1,071,000. Sepio Capital LP lifted its position in UnitedHealth Group by 0.3% during the 2nd quarter. Sepio Capital LP now owns 5,822 shares of the healthcare conglomerate’s stock worth $2,965,000 after acquiring an additional 20 shares during the period. Finally, Texas Capital Bank Wealth Management Services Inc lifted its position in UnitedHealth Group by 6.6% during the 2nd quarter. Texas Capital Bank Wealth Management Services Inc now owns 16,134 shares of the healthcare conglomerate’s stock worth $8,216,000 after acquiring an additional 994 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have commented on UNH shares. KeyCorp reaffirmed an “overweight” rating and set a $650.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Deutsche Bank Aktiengesellschaft boosted their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective for the company in a report on Friday, January 10th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday. Finally, Piper Sandler decreased their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. One analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group has a consensus rating of “Buy” and an average target price of $627.74.

UnitedHealth Group Trading Up 0.5 %

UNH opened at $532.26 on Friday. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The stock has a market capitalization of $489.83 billion, a PE ratio of 34.34, a P/E/G ratio of 1.41 and a beta of 0.62. The business’s 50 day moving average price is $542.24 and its 200 day moving average price is $563.54. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same period in the prior year, the firm earned $5.83 earnings per share. The firm’s revenue was up 6.8% compared to the same quarter last year. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 29.74 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.58%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is 54.19%.

Insider Activity

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.